Sugi Predict

Sugi Predict / Compounds / SCHEMBL101401

SCHEMBL101401

SCHEMBL101401

CCCCCC(C)[C](C)C

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.56
▸ OPRM1 P35372 1/20 0.48
▸ FDPS P14324 4/20 0.46
▸ ACE2 Q9BYF1 1/20 0.45
▸ SPHK1 Q9NYA1 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ FFAR1 O14842 2/20 0.40
▸ FFAR4 Q5NUL3 1/20 0.40
▸ GPR84 Q9NQS5 3/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37117 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL7795348 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL1176710 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL1279390 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL502907 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL2301401 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL20520239 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL20520255 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL20520253 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1
SCHEMBL1358107 0.97 CA1 (0.54) CA1OPRM1FDPSACE2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 — — US claimed
US-20230073802-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2023-03-09 — — US claimed
US-20220387376-A1 Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents NATURAL EXTRACTION SYS LLC (US) 2022-12-08 — — US claimed
US-20220387351-A1 Compositions and Methods Related to Organic Oxides Natural Extraction Systems, LLC 2022-12-08 — — US claimed
WO-2021158573-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 — — WO claimed
WO-2021158575-A1 COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 — — WO claimed
WO-2021158714-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2021-08-12 — — WO claimed
WO-2021087291-A1 COMPOSITIONS AND METHODS RELATED TO ORGANIC OXIDES Natural Extraction Systems, LLC (US) 2021-05-06 — — WO claimed
WO-2021076936-A1 COMPOSITIONS COMPRISING CANNABINOID MOLECULES THAT ARE DISSOLVED IN WATER-MISCIBLE SOLVENTS Natural Extraction Systems, LLC (US) 2021-04-22 — — WO claimed
WO-2021041637-A1 COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL Natural Extraction Systems, LLC (US) 2021-03-04 — — WO claimed
US-10202322-B2 Resorcinol derivatives SUTTER BAY HOSPITALS (US) 2019-02-12 — — US claimed
CN-109072129-A Cleaning agent composition 花王株式会社 2018-12-21 — — CN claimed
US-20180170846-A1 RESORCINOL DERIVATIVES SUTTER WEST BAY HOSPITALS 2018-06-21 — — US claimed
US-20130209483-A1 CANNABIDINOID DERIVATIVES SUTTER WEST BAY HOSPITALS (US) 2013-08-15 — — US claimed
EP-2601166-A1 COSMETIC PREPARATIONS Cognis IP Management GmbH (DE) 2013-06-12 — — EP claimed
US-20130131188-A1 Cosmetic Preparations COGNIS IP MANAGEMENT GMBH (DE) 2013-05-23 — — US claimed
EP-2426101-A1 Cosmetic preparations Cognis IP Management GmbH (DE) 2012-03-07 — — EP claimed
WO-2012016642-A1 COSMETIC PREPARATIONS COGNIS IP MANAGEMENT GMBH (DE) 2012-02-09 — — WO claimed
CN-101368072-B Bond composition and optical element CHEIL IND CO LTD 2011-05-11 — — CN claimed
US-4319987-A Branched alkyl ether amines as iron ore flotation aids EXXON RESEARCH & ENGINEERING CO. (US) 1982-03-16 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220387376-A1 Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents CNR2, CNR1, PHOSPHO1 CA1 2098/4885OPRM1 63/4885FDPS 2150/4885
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES FABP2, FABP4, GUSB CA1 666/4885OPRM1 3826/4885FDPS 1554/4885
US-20130131188-A1 Cosmetic Preparations CYP1B1, CBR1, ACOX3 CA1 4471/4885OPRM1 745/4885FDPS 2304/4885
US-10202322-B2 Resorcinol derivatives CNR1, CNR2, RCOR1 CA1 4769/4885OPRM1 204/4885FDPS 574/4885
US-20220387351-A1 Compositions and Methods Related to Organic Oxides LPO, SLCO2A1, SLCO2B1 CA1 528/4885OPRM1 26/4885FDPS 426/4885
US-20130209483-A1 CANNABIDINOID DERIVATIVES CNR2, CNR1, GPR18 CA1 4299/4885OPRM1 135/4885FDPS 1343/4885
US-20180170846-A1 RESORCINOL DERIVATIVES CNR1, CNR2, RCOR1 CA1 4769/4885OPRM1 204/4885FDPS 574/4885
US-20230073802-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS CNR2, CNR1, FAAH CA1 220/4885OPRM1 12/4885FDPS 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.